Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sebia
Lisses, Île-de-France, Francesebia.com ↗
- Ownership
- Private
- Employees
- ~1001
- Development stage
- Other
01
Overview
Sebia is a global leader in clinical protein electrophoresis and capillary electrophoresis-based diagnostics. Its commercialized platforms are widely used for the diagnosis and monitoring of multiple myeloma, diabetes management via HbA1c assays, detection of hemoglobinopathies, autoimmune disorders, and other rare conditions. The company continues to innovate with new tests and automated equipment in its pipeline.
- Therapeutic areas
- HematologyEndocrinologyOncologyImmunology
- Modalities
- DeviceReagent
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on Sebia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sebia.